Clinical trials
Phase 3 Neoplasms trials in Peru
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Bayer | 2 |
| Novartis Pharmaceuticals | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| Celldex Therapeutics | 1 |
| Centus Biotherapeutics Limited | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 14 |
| Breast Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasms by Site | 2 |
| Prostatic Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Brain Neoplasms | 1 |
| Breast Diseases | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.